Skip to main content
OpenTrials
Completed

NCT Number: NCT02347930

Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury

Establish an integrated evaluation system of ultrasound technology for the prognosis of acute kidney injury, and in order to achieve non-invasive, reliable early diagnosis "gold standard". Set up collabration with the expert in National Cheng Kung University Medical Center of Taiwan who did a lot of excellent work in basic research of prevention the progression of acut kidney injury. Study the experience about prevention progression of kidney disease in clinical and basic field. Establish cooperation with the professional in Hong Kong University of Science and Technology. To set up the system of natural products research and assess the Astragalus medicinal value.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Kidney Injury Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Renal Insufficiency Urogenital Diseases Urologic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of nephrology , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200127, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects must satisfy the following criteria to be enrolled in the study:
  • Clinical diagnosis of acute or chronic kidney injury
  • Male or female, aged 18-80 years old
  • signed informed consent
  • Patients can breathe in, breathe out and hold their breathe with ease, communication without difficulty.

Exclusion criteria

  • Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • Refuse to sign informed consent
  • allergy to micro bubble hexafluoride drug
  • Patients with cardiopulmonary insufficiency, pleural effusion, pulmonary infections
  • Patients with asthma, chronic bronchitis
  • Patients with pregnancy
  • Patients can't cooperate or have a difficulty in breathing in, breathing out or holding their breathe
  • Patients beening diagnosed with End-stage kidney disease.

Treatment and study plan

kidney ultrasound

Other

kidney ultrasound

Primary outcomes

  1. compare the results of kidney ultrasound with biomarkers of acute kidney injury

    Time frame: up to 24 months

Sponsors and collaborators

Lead sponsor

RenJi Hospital

Other

Collaborators

  • China-Japan Friendship Hospital
  • National Cheng-Kung University Hospital

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Jan 28, 2015
Registry last updated
Nov 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.